Preoperative Beta-Blocker Use Should Not Be a Quality Metric for Coronary Artery Bypass Grafting

Submitted by: Erica CurcioGold Contributor

Source: Annals of Thoracic Surgery
Source URL: http://www.annalsthoracicsurgery.org/article/S0003-4975%2813%2901146-6/abstract

Keywords:

Author(s): Damien J. LaPar, Ivan K. Crosby, Irving L. Kron, John A. Kern, Edwin Fonner, Jeffrey B. Rich, Alan M. Speir, Gorav Ailawadi

In the US, preoperative beta-blockade is a hospital quality metric that must be addressed at the time of each operation.  This study reviewed STS Database data for isolated CABG in nearly 44,000 pts.  After risk adjustment, beta-blockade had no effect on mortality, morbidity, or hospital resource utilization.  The authors suggest that beta-blockade is not a useful quality metric for CABG. 

Add Comments

ADD TO PLAYLIST

Related Content